The level of 9,390 is likely to act as a resistance level, which is 38.2 per cent retracement level. Meanwhile on the downside, an immediate support is seen around 9,180 level, followed by 8,909. Stocks in news: Reliance Industries, Just Dial, UPL, Shipping Corporation of India.

Nifty rallied sharply in the first half of the trading session on Monday however, in the second half of the trading session, Nifty lost its momentum and came off the days’ high but still managed to close with handsome gains. And, if we go by the early indication from SGX Nifty, there is a possibility that Nifty may continue its rally on Tuesday too.

Indian wind energy service provider, Inox Wind Ltd, informed that all the three manufacturing plants of the company have resumed operations now.

Considering the daily time frame, the banking benchmark index, Bank Nifty is trading in symmetrical triangle pattern since the last 21 trading sessions.

The stock of Cholamandalam Investment & Finance Company Limited has formed a homing pigeon candlestick pattern on the daily timeframe.

One of the country’s leading healthcare companies, Lincoln Pharmaceuticals Limited, informed the bourses on Monday that it has received approval from Food & Drugs Control Administration (FDCA) Gujarat, to manufacture Hydroxychloroquine (HCQ), among other critical drugs to fight COVID-19.

Sensex climbed by 415.86 points which is 1.333 per cent to be at the level of 31,743.08 while, Nifty rose by 127.90 points, which is 1.40 per cent to be at the level of 9,282.30 as RBI announced Rs 50,000 crore liquidity support for mutual funds. Post which, AMC stocks had gained by more than five per cent.

BEML has bagged orders worth Rs 398 crore (inclusive of taxes) from  Coal India Limited (CIL), for the supply of seven 150-T dumpers and eight 190-T dumpers under the trial cum sale, along with a contract for spare parts for eight years on April 24, 2020.

Balkrishna Industries has partially resumed its manufacturing operations pursuant to the recent notifications and directives of the government and local authorities

On Monday, Dr Reddy’s Laboratories announced the launch of Fenofibrate tablets USP in US market, a drug approved by United States Food & Drug Administration (USFDA).